ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
Crossref DOI link: https://doi.org/10.1038/s41598-020-79918-3
Published Online: 2021-01-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fakhar, Zeynab
Khan, Shama
AlOmar, Suliman Y.
Alkhuriji, Afrah
Ahmad, Aijaz
Text and Data Mining valid from 2021-01-08
Version of Record valid from 2021-01-08
Article History
Received: 11 June 2020
Accepted: 1 December 2020
First Online: 8 January 2021
Competing interests
: The authors declare no competing interests.